Specific themes:
Acute HCV infection: transmission and intervention
Potential for targeted abstract driven session and development of collaborative research opportunities
Presentations:
-
Epidemiology of acute HCV among HIV-infected MSM
-
Early HCV therapeutic intervention: an opportunity for HCV treatment as prevention?
Viral hepatitis epidemiology and disease burden
Presentations:
-
The impact of chronic hepatitis on morbidity and mortality in people with HIV
-
Will IFN-free DAA therapy reverse advanced liver disease in people with HIV/HCV coinfection?
HBV prevention and management
Presentations:
-
Coverage of tenofovir-based ART in developed and developing country settings
-
Options for HBV management in the setting of tenofovir toxicity
-
HBV vaccine coverage and strategies for people with HIV
Development of new HCV therapies: specific issues for HIV coinfection
Presentations:
-
Is there a role for first generation HCV protease inhibitors in people with HIV?
-
IFN-free DAA development and optimising regimens for HIV/HCV coinfection
-
Drug - drug interactions in the context of DAA-based HCV therapy
Access to new HCV therapies
There is an opportunity to make this theme a central component of the meeting, with panel discussion and development of a meeting-based position statement and strategy on enhancing access to IFN-fee DAA regimens
Presentations:
-
Access to IFN-free DAA therapy: lessons from ART access strategies
-
Human rights and access to new HCV therapies
-
Public health advocacy and HCV therapy access
-
HCV antiviral therapy drug pricing